Hummingbird Bioscience is a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases. The Hummingbird Bioscience model combines computational and systems biology, and wet lab drug discovery in a multi-disciplinary, collaborative environment spanning initial discovery through clinical development. We harness this integrated approach across target identification and patient selection, enabling our team to increase the efficiency of translating novel scientific insights while reducing the inherent risk in drug discovery and development. At Hummingbird Bioscience, our commitment to rigorous science, teamwork, and intellectual integrity underpins our passion to accelerate the journey of new drugs from concept to clinic.
Sign up for our updates here: https://bit.ly/HMBDNews
Company Details
- Employees
- 76
- Founded
- -
- Address
- 61 Science Park Road, #06-15/24,
- co****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- hummingbirdbioscience.com
- Keywords
- Allozymes.
- HQ
- Singapore
Hummingbird Bioscience Questions
Hummingbird Bioscience's website is hummingbirdbioscience.com
Hummingbird Bioscience's LinkedIn profile is https://www.linkedin.com/company/hummingbird-bioscience
Hummingbird Bioscience has
76 employees.
View email and phone details for 76
employees at Hummingbird Bioscience.
Hummingbird Bioscience's industry is
Biotechnology Research
Hummingbird Bioscience's top competitors are
Hilleman Laboratories,
Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics),
Cellvec Pte Ltd,
Tessa Therapeutics Ltd,
Engine Biosciences,
Allozymes,
Lucence,
Albatroz Therapeutics,
Mirxes,
Callio Therapeutics.
Hummingbird Bioscience's support email address is contact@hummingbirdbio.com
Hummingbird Bioscience's categories are Biotechnology Research
Hummingbird Bioscience's founding year is 2015
